Fusion Fuel reported H1 2026 revenue of €6.5 million and expects full-year revenue of €16–18 million amid hydrogen project ...

ASML reported third-quarter 2026 net sales of €11.7 billion, net income of €4.96 billion, and raised its capacity outlook for ...

The Progressive Corporation reported Q3 2026 revenue of $22.3 billion and EPS of $4.37, slightly below analyst expectations.

Sarepta reported preclinical data showing SRP-1003 reduced toxic DMPK transcripts in nuclear and cytoplasmic compartments for ...

Alpha Compute secured an $81.7 million four-year GPU compute agreement covering 576 NVIDIA B300 GPUs in its ALPHA-03 cluster.

Takeda reported Phase 2/3 IgGNITE trial results showing TAK-881 may reduce infusion burden for primary immunodeficiency ...

Viking Therapeutics initiated Phase 3 SUNRISE trials for oral VK2735 after Phase 2 results showed up to 12.2% weight ...

Parabilis Medicines launched a zolucatetide dose-ranging cohort in familial adenomatous polyposis after early polyp ...

Morgan Stanley reported Q3 2026 revenue of $20.34 billion, EPS of $3.03, and strong growth across trading and wealth ...

Fastenal reported Q3 2026 revenue of $2.46 billion, EPS of $0.35, and strong operating margins as sales growth accelerated.

Eton Pharmaceuticals entered U.S. licensing agreements for LIBERVANT, a seizure-cluster treatment expected to launch in 2027 ...

Bank of America reported Q3 2026 revenue of $29.96 billion and adjusted EPS of $1.08, impacted by a $1.2 billion regulatory ...